Resection and radiochemotherapy of pancreatic cancer – the future?

1998 ◽  
Vol 383 (2) ◽  
pp. 134-144 ◽  
Author(s):  
K. H. Link ◽  
A. Formentini ◽  
G. Leder ◽  
G. Fortnagel ◽  
N. Sartori ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
The Future

Immune Therapy in Pancreatic Cancer: Now and the Future?

2015 ◽  
Vol 10 (4) ◽  
pp. 317-325 ◽  
Author(s):  
Yue Zhang ◽  
Minsig Choi
Keyword(s):  
Pancreatic Cancer ◽  
Immune Therapy ◽  
The Future

scholarly journals Current State of “Omics” Biomarkers in Pancreatic Cancer

2021 ◽  
Vol 11 (2) ◽  
pp. 127 ◽  
Author(s):  
Beste Turanli ◽  
Esra Yildirim ◽  
Gizem Gulfidan ◽  
Kazim Yalcin Arga ◽  
Raghu Sinha
Keyword(s):  
Pancreatic Cancer ◽  
Personalized Medicine ◽  
Biomarker Discovery ◽  
Survival Rates ◽  
Postoperative Recurrence ◽  
Molecular Biomarkers ◽  
Background Information ◽  
Current State ◽  
Pancreatic Cancer Screening ◽  
The Future

Pancreatic cancer is one of the most fatal malignancies and the seventh leading cause of cancer-related deaths related to late diagnosis, poor survival rates, and high incidence of metastasis. Unfortunately, pancreatic cancer is predicted to become the third leading cause of cancer deaths in the future. Therefore, diagnosis at the early stages of pancreatic cancer for initial diagnosis or postoperative recurrence is a great challenge, as well as predicting prognosis precisely in the context of biomarker discovery. From the personalized medicine perspective, the lack of molecular biomarkers for patient selection confines tailored therapy options, including selecting drugs and their doses or even diet. Currently, there is no standardized pancreatic cancer screening strategy using molecular biomarkers, but CA19-9 is the most well known marker for the detection of pancreatic cancer. In contrast, recent innovations in high-throughput techniques have enabled the discovery of specific biomarkers of cancers using genomics, transcriptomics, proteomics, metabolomics, glycomics, and metagenomics. Panels combining CA19-9 with other novel biomarkers from different “omics” levels might represent an ideal strategy for the early detection of pancreatic cancer. The systems biology approach may shed a light on biomarker identification of pancreatic cancer by integrating multi-omics approaches. In this review, we provide background information on the current state of pancreatic cancer biomarkers from multi-omics stages. Furthermore, we conclude this review on how multi-omics data may reveal new biomarkers to be used for personalized medicine in the future.

Pancreatic Cancer: The Challenge of the Future in Tumorigenesis-based Prevention

2011 ◽  
Vol 35 (9) ◽  
pp. 2182-2183
Author(s):  
Ernst Hanisch ◽  
Charalabos Batsis
Keyword(s):  
Pancreatic Cancer ◽  
The Future

Computed tomography findings for predicting the future occurrence of pancreatic cancer: value of pancreatic volumetry

2021 ◽  
Author(s):  
Yuki Kawaji ◽  
Takanori Yoshikawa ◽  
Katsuji Nakagawa ◽  
Tomoya Emori ◽  
Junya Nuta ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Pancreatic Cancer ◽  
The Future

scholarly journals The Promising Role of TGF- β/SMAD4 in Pancreatic Cancer: The future targeted therapy

2019 ◽  
Vol 3 (2) ◽  
pp. 1-7
Author(s):  
Sunjida Ahmed ◽  
Christopher Schwartz ◽  
M Dewan ◽  
Ruliang Xu
Keyword(s):  
Pancreatic Cancer ◽  
Targeted Therapy ◽  
The Future

scholarly journals The Tumor Microenvironment of Pancreatic Cancer

Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 3076
Author(s):  
Eva Karamitopoulou
Keyword(s):  
Pancreatic Cancer ◽  
Tumor Microenvironment ◽  
Pancreatic Ductal Adenocarcinoma ◽  
Incidence Rates ◽  
Ductal Adenocarcinoma ◽  
Dismal Prognosis ◽  
The Future ◽  
Rising Incidence

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis along with rising incidence rates and will be responsible for many cancer deaths in the future [...]

Rewriting the Future for Pancreatic Cancer Patients

2015 ◽  
Vol 30 (6) ◽  
pp. 74-75
Author(s):  
Anitra Engebretson ◽  
Nicole Lise Feingold
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
The Future

Neo-adjuvant therapy for pancreatic cancer: hope for the future

2019 ◽  
Vol 13 (6) ◽  
pp. 579-589
Author(s):  
Erkut Borazanci ◽  
Steven Sckolnik ◽  
Albert Amini
Keyword(s):  
Pancreatic Cancer ◽  
Adjuvant Therapy ◽  
The Future

Health Care Disparities and the Future of Pancreatic Cancer Care

2021 ◽  
Vol 30 (4) ◽  
pp. 759-771
Author(s):  
Marianna V. Papageorge ◽  
Douglas B. Evans ◽  
Jennifer F. Tseng
Keyword(s):  
Health Care ◽  
Pancreatic Cancer ◽  
Cancer Care ◽  
Health Care Disparities ◽  
The Future
Sign in / Sign up

Export Citation Format

Share Document